Mahoney Michael F 4

What Happened

• Michael F. Mahoney, a director of CVS Health Corp (CVS), was granted 1,737.005 deferred stock units (derivative awards) on 2026-05-14. The units were valued at $97.15 each for a total reported value of $168,750. The grant is reported as an "A" (award/grant).

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-15 (timely filing).
• Price/value used: $97.15 per share; total value $168,750.
• Securities received: 1,737.005 deferred stock units (derivative), not immediate common shares.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes: F1 — units issued for deferral of a semi‑annual retainer under the Issuer's non‑employee director compensation policy and 2017 Incentive Compensation Plan. F2 — each deferred stock unit will convert into one share of common stock and be issued in the future as elected by the reporting person.
• Transaction code: A = Award/Grant; no 10b5-1 or tax‑withholding noted in the excerpt.

Context

• These are deferred stock units granted as part of routine non‑employee director compensation (semi‑annual retainer deferral). They are derivative awards that will convert to common shares in the future per the director’s election, so this is not an open‑market purchase or sale and does not by itself indicate a change in insider sentiment.